MRNA
Price:
$72.89
Market Cap:
$28.02B
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; ca...[Read more]
Industry
Biotechnology
IPO Date
2018-12-07
Stock Exchange
NASDAQ
Ticker
MRNA
According to Moderna, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 26.81B. This represents a change of -31.58% compared to the average of 39.19B of the last 4 quarters.
The mean historical Enterprise Value of Moderna, Inc. over the last ten years is 32.47B. The current 26.81B Enterprise Value has changed 8.16% with respect to the historical average. Over the past ten years (40 quarters), MRNA's Enterprise Value was at its highest in in the September 2021 quarter at 150.52B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.
Average
32.47B
Median
21.64B
Minimum
613.74M
Maximum
96.42B
Discovering the peaks and valleys of Moderna, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 937.41%
Maximum Annual Enterprise Value = 96.42B
Minimum Annual Increase = -91.07%
Minimum Annual Enterprise Value = 613.74M
Year | Enterprise Value | Change |
---|---|---|
2023 | 36.33B | -47.17% |
2022 | 68.77B | -28.68% |
2021 | 96.42B | 157.67% |
2020 | 37.42B | 487.74% |
2019 | 6.37B | 937.41% |
2018 | 613.74M | -91.07% |
2017 | 6.87B | -1.17% |
The current Enterprise Value of Moderna, Inc. (MRNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
67.17B
5-year avg
49.06B
10-year avg
32.47B
Moderna, Inc.’s Enterprise Value is greater than CureVac N.V. (390.67M), greater than Novavax, Inc. (1.40B), greater than CohBar, Inc. (-4942363.00), greater than Reata Pharmaceuticals, Inc. (6.68B), less than Ocean Biomedical, Inc. (0), greater than Enveric Biosciences, Inc. (44.98M), greater than Hepion Pharmaceuticals, Inc. (1.02M), greater than Elevation Oncology, Inc. (2.24M), greater than AVROBIO, Inc. (8.41M), greater than Rain Therapeutics Inc. (-85302404.00), greater than Krystal Biotech, Inc. (7.16M), greater than Intellia Therapeutics, Inc. (4.95B), greater than Editas Medicine, Inc. (1.98B), greater than Vertex Pharmaceuticals Incorporated (270.35M), less than Beam Therapeutics Inc. (117.15B), greater than Ginkgo Bioworks Holdings, Inc. (1.79B), greater than null (694.60M),
Company | Enterprise Value | Market cap |
---|---|---|
390.67M | $614.60M | |
1.40B | $1.86B | |
-4942363.00 | $1.25M | |
6.68B | $6.57B | |
0 | $33.96M | |
44.98M | $4.53M | |
1.02M | $4.20M | |
2.24M | $36.94M | |
8.41M | $5.24M | |
-85302404.00 | $44.01M | |
7.16M | $5.29B | |
4.95B | $2.00B | |
1.98B | $296.09M | |
270.35M | $120.79B | |
117.15B | $1.92B | |
1.79B | $975.05M | |
694.60M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Moderna, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Moderna, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Moderna, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Moderna, Inc. (MRNA)?
What is the 3-year average Enterprise Value for Moderna, Inc. (MRNA)?
What is the 5-year average Enterprise Value for Moderna, Inc. (MRNA)?
How does the current Enterprise Value for Moderna, Inc. (MRNA) compare to its historical average?